Levalbuterol Hydrochloride
NDC Package 66993-021-27

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Levalbuterol Hydrochloride is a . Marketed by Prasco Laboratories, this product is identified by NDC 66993-021 and is authorized under FDA application NDA020837.

Identification & Billing

NDC Package Code
66993-021-27
Package Description
2 POUCH in 1 CARTON / 12 VIAL, SINGLE-DOSE in 1 POUCH (66993-021-35) / 3 mL in 1 VIAL, SINGLE-DOSE
Product Code
66993-021
11-Digit Billing Format
66993002127
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Levalbuterol Hydrochloride
Dosage Form
-

Regulatory & Marketing

Labeler Name
Prasco Laboratories
FDA Application #
NDA020837
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
02-27-2015
End Marketing Date
05-31-2022
Listing Expiration
05-31-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J7614
Source: PDAC
LEVALBUTEROL, INHALATION SOLUTION, FDA-APPROVED FINAL PRODUCT, NON-COMPOUNDED, ADMINISTERED THROUGH DME, UNIT DOSE, 0.5 MG
HCPCS Dosage 0.5 MG
Units / Pkg

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66993-021-27 identifies a specific commercial package of 2 pouch in 1 carton / 12 vial, single-dose in 1 pouch (66993-021-35) / 3 ml in 1 vial, single-dose of Levalbuterol Hydrochloride, labeled by Prasco Laboratories. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Prasco Laboratories on February 27, 2015. The current certification is valid through May 31, 2022.

How is this Prasco Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66993002127. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66993-021-27
11-Digit CMS (5-4-2)
66993-0021-27

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.